Early treatment with Copaxone ‘benefits patients’
Early treatment with Copaxone ‘benefits patients’
Teva has announced new data on the safety and efficacy of Copaxone (glatiramer acetate injection) 40mg/mL in patients with relapsing forms of multiple sclerosis (MS)..... Read More - http://www.ms-uk.org/copaxone
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 2 Replies
- 1389 Views
-
Last post by NHE
-
- 0 Replies
- 1099 Views
-
Last post by frodo
-
- 0 Replies
- 1235 Views
-
Last post by frodo
-
- 0 Replies
- 1327 Views
-
Last post by NHE
-
- 0 Replies
- 1634 Views
-
Last post by DIM
-
- 0 Replies
- 11294 Views
-
Last post by NHE
-
- 0 Replies
- 1345 Views
-
Last post by frodo
-
- 0 Replies
- 1389 Views
-
Last post by NHE
-
- 0 Replies
- 2093 Views
-
Last post by frodo